Can you guess what our next recombinant protein will be? 👀

We're a supplier on Scientist.com! 🙌 Scientist.com aims to speed up medical research, enabling cures for all human disease by 2050. We're supporting this mission with our EntoEngine™ 🪰🧬, leveraging transgenic Drosophila to make proteins at scale: bit.ly/3xVez1V

Inter-leukin' good! 👀📸 We’re jazzed about our #interleukin going out the door yesterday. #IL2 is the beginning of more exciting launches to come. 🙌 View our IL-2 here 👉 bit.ly/3SdFQDx

An offhand idea sparked Matt Anderson-Baron (’13 BSc, ’19 PhD) and his wife Jalene (’12 BA, ’16 MA) to create a business - Future Fields - that harnesses fruit flies to develop life-saving therapies. #UAlberta UAlberta Alumni From New Trail: bit.ly/3Lus4sw

Fascinating new research on IL-11 from Duke-NUS Medical School and more! 🐁 Studies found that inhibition of IL-11 increased lifespan in mice, with current data suggesting that anti-IL-11 therapy given in late life increases median lifespan by >20% 🤯 Read publication: go.nature.com/3SeUVoG

We're pleased to be a sponsor for this year's Gordon Research Conferences Membrane Transport Proteins Conference! 🙌 Excited for the new insights into structure, function, and regulation of critical #membranetransportproteins in health and disease. 🗣️ View program: bit.ly/3Yeptuh

ICYMI - we launched a new protein last week. 👀🩵 Bioactive, high in purity, and excelling in safety, what makes this #IL2 unique is that it's made by transgenic fruit flies 🪰 in our Green-certified lab. 🥼💚 Request a free sample for your research 👇 bit.ly/4bGksOg

Lots of fun finds from last week! Our #Sustainability Committee hosted a team ABC (Appliances 📻, Boredom Busters 📚, Clothing 👗) Swap event to promote #circulareconomy and #ecofriendly values in an engaging way. Here's to more sustainable initiatives and fun in the future! ♻️

Quality is upheld by every Future Fielder, but we can thank our QA team for keeping us in check. ✅ QA leads our document management system and oversees manufacturing activities to ensure consistent product quality. 🙌 More on quality at Future Fields: bit.ly/4bZTmBV

Exciting new research from Sorbonne Université! 🙌 Studies found that providing low doses of #IL2 activated regulatory T cells #Tregs reduced #multiplesclerosis disease activity. 🧠 Read the publication: bit.ly/3SFeVka

"How do I reconstitute my lyophilized recombinant protein?" This is a common question we get from our customers. Paige, Senior Research Scientist from our Protein Biochemistry team walks us through the reconstitution process. 👩‍🔬 Watch below 👇 bit.ly/4dfC0SP

Everyone talks about reliability - but what does it actually look like? 🥼🔍 For starters, our QC team conducts in-process testing at critical control points to ensure batch-to-batch consistency. 🔁 Learn more about quality at Future Fields 👉 bit.ly/4ddXlvV

Product compliance goes beyond the lab - we ensure our products are in line with government regulations. Our regulatory experts are here to answer any questions you may have! 🙌 Learn more about quality at Future Fields 👉: bit.ly/4dk8RGi

At ZPC, we teamed up with G2V Optics and Future Fields on Aug 15th, 2024, for an afternoon of connection, games, and fun! It was a fantastic break from the routine and a great way to bond with fellow Edmonton innovators. 🔗 zpcryo.com/post/celebrati… #YEGStartUps #Community

YEG Deeptech Summer Shindig was for the books 😎☀️ We beat the heat last week with some pretty cool lab tours, ice cream making, and swapping stories of building a #deeptech #startup in Edmonton. 🚀 Thanks for inviting us out, Zero Point Cryogenics, G2V Optics! #yegtech #yegstartup

🚨 Exciting findings from Ted Price director of CAPS at UT Dallas, Stephanie Shiers! New research from Shiers et. al link Nageotte nodules to #DiabeticNeuropathy #DPN. These findings resolve a 100-year mystery of the nature of these nodules. 🌟 Read the paper 👇 bit.ly/4e2mtpp

EntoEngine™ in 1 minute ☝️🪰 Same purity and quality as traditional systems, but using a *whole organism* (transgenic #Drosophila) instead of single cells in tanks. The result? Cost-effective multicellular expression at scale. Ask us about our tech 👉 bit.ly/3Mdm3Rs

📢 Welcoming Dr. Haresh Mirchandani to our Advisory Board! 👏 With ~30 years of experience in biopharma, Haresh brings invaluable insight into business dev + strategic partnerships. Thrilled to have his leadership + expertise as we make the unmakeable at Future Fields! 🪰🧬🌎

📍 See you in Boston! 👋 Discovery on Target highlights hot targets, tech advancements, and target validation strategies. Thrilled to share more on how our novel #synbio platform, the EntoEngine™ 🪰 can be applied for bioprocessing and therapeutic development at #BostonDOT24!